NCT06946225 2026-01-08ACTengine® IMA203 Combined With mRNA-4203Immatics US, Inc.Phase 1 Recruiting15 enrolled
NCT05296564 2025-10-02Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic CancersHadassah Medical OrganizationPhase 1/2 Recruiting3 enrolled